Department of Defense INSTRUCTION
x9tnk
x9tnk
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
DoDI 5000.02, January 7, 2015<br />
risk reduction prototypes will be included if they will materially reduce engineering and<br />
manufacturing development risk at an acceptable cost. If competitive prototyping is not<br />
considered feasible, single prototypes at the system or subsystem level will be considered.<br />
a. Risk reduction prototypes will be included if they will materially reduce<br />
engineering and manufacturing development risk at an acceptable cost. Risk reduction<br />
prototypes can be at the system level or can focus on sub-systems or components.<br />
b. A competitive prototype, or if this is not feasible, a single prototype or<br />
prototyping <strong>of</strong> critical subsystems prior to Milestone B is statutorily required to be part <strong>of</strong> the<br />
Acquisition Strategy for MDAPs and is a regulatory requirement for all other programs. The<br />
MDA may waive the competitive prototyping requirement at or prior to Milestone A if:<br />
I. The cost <strong>of</strong> producing competitive prototypes exceeds the expected lifecycle<br />
benefits (in constant dollars) <strong>of</strong> producing the prototypes, including the benefits <strong>of</strong><br />
improved performance and increased technological and design maturity that may be achieved<br />
through competitive prototyping; or<br />
II. The department would be unable to meet critical national security<br />
objectives without such a waiver.<br />
3. There are a number <strong>of</strong> ways to structure this phase which should be tailored to<br />
reduce the specific risks associated with the product being acquired. Technology Readiness<br />
Levels, described in the Technology Readiness Assessment (TRA) Guidance (Reference (e) (f)),<br />
should be used to benchmark technology risk during this phase; however, these indices are rough<br />
benchmarks, and not conclusive about the degree <strong>of</strong> risk mitigation needed prior to development.<br />
Deeper analysis <strong>of</strong> the actual risks associated with the preferred design and any recommended<br />
risk mitigation must be conducted and provided to the MDA.<br />
(c) The Acquisition Strategy will guide this phase. Multiple technology development<br />
demonstrations, defined in the acquisition strategy, may be necessary before the operational user<br />
and material materiel developer can substantiate that a preferred solution is feasible, affordable,<br />
and supportable; satisfies validated capability requirements; and has acceptable technical risk.<br />
Critical program information will be identified during this phase and program protection<br />
measures to prevent disclosure <strong>of</strong> critical information will be implemented consistent with<br />
section 13 in Enclosure 3. Planning for EMD, production, developmental and operational test,<br />
and life-cycle sustainment <strong>of</strong> proposed products will occur during this phase. The government<br />
will update the program IP Strategy (see paragraph 6a(4) <strong>of</strong> Enclosure 2) to ensure the ability to<br />
compete future sustainment efforts consistent with the Acquisition Strategy to include<br />
competition for spares and depot repair.<br />
(d) During this phase, and timed to support CDD validation (or its equivalent), the<br />
Program Manager will conduct a systems engineering trade-<strong>of</strong>f analysis showing how cost and<br />
capability vary as a function <strong>of</strong> the major design parameters. The analysis will support the<br />
assessment <strong>of</strong> refined KPPs/KSAs in the CDD. Capability requirements proposed in the CDD<br />
(or equivalent requirements document) should be consistent with program affordability goals.<br />
Change 2, 02/02/2017 22